Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. (SYRE) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Spyre Therapeutics, Inc. (NASDAQ:SYRE).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerSYRE Technical Analysis Summary
Spyre Therapeutics, Inc. stock currently shows a bullish trend, supported by momentum and strong buying pressure.
This mix signals that Spyre Therapeutics, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 69.06
Stochastic %K: 78.77
Williams %R: -17.13
Rate of Change (ROC): 18.41
Takeaway:Spyre Therapeutics, Inc. shows strong bullish momentum, with buyers firmly in control.
MACD: 1.76
ADX: 23.56
ATR (14): 2.48
CCI (14): 223.54
Takeaway:Spyre Therapeutics, Inc. shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Spyre Therapeutics, Inc. trades near the upper band, signaling overbought conditions and risk of pullback.
Takeaway:Spyre Therapeutics, Inc. trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:SYRE shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
Overall Recommendation:Spyre Therapeutics, Inc. currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.